Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Note: This consent is given subject to the following condition:

• Apo-Riluzole 50mg tablets can only be prescribed by specialist physicians who care for patients with Motor Neuron Disease, neurologists and palliative care physicians.

Note: This consent is valid for two years from the date of publication of this notice.

Note: This consent is given subject to the following condition:

• The vaccine may only be marketed or distributed in accordance with the directives contained in the current version of the New Zealand Influenza Pandemic Action Plan.

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 2nd day of February 2018.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).